Glycans in Drug Design
Glycans are components of many bio-therapeutic agents, ranging from natural products to molecules based on rational design to recombinant glycoproteins. The glycan components of these agents can be important determinants of their biological activity and therapeutic efficacy. Biochemistry and Glycobiology involves a multidisciplinary study of carbohydrate-binding proteins (lectins), glycolipids and some other plant proteins that are capable of interacting with endogenous or foreign (macro) molecules.
Related Conference of Glycans in Drug Design
October 13-14, 2025
17th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
Glycans in Drug Design Conference Speakers
Recommended Sessions
- Glyco-Biomarkers
- Genomics
- Glycans in Diseases and Therapeutics
- Glycans in Drug Design
- Glycans in Genetic Disorders
- Glyco Immunology
- Glyco-Bioinformatics
- Glyco-proteomics
- Glycobiology
- Glycobiology and Biotechnology
- Glycobiology and Structural biology
- Glycobiology in Personalized Medicine
- Glycomics and Metabolomics
- Glycoprotein Technologies
- Mass Spectrometry
Related Journals
Are you interested in
- 3-D Structure Determination - Structural Biology 2025 (Germany)
- 3D Structure Determination - Structural Biology-2025 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2025 (France)
- Advancements in structural Biology - Structural Biology 2025 (Germany)
- AI & Computational Structural Biology - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology-2025 (France)
- Biochemistry and Biophysics - Structural Biology 2025 (Germany)
- Computational Approach in Structural Biology - Structural Biology-2025 (France)
- Computational Approach in Structural Biology - Structural Biology 2025 (Germany)
- Drug Designing and Biomarkers - Structural Biology-2025 (France)
- Drug Designing and Biomarkers - Structural Biology 2025 (Germany)
- Frontiers in Structural Biology - Structural Biology 2025 (Germany)
- Gene Regulation and Cell Signaling - Structural Biology 2025 (Germany)
- Hybrid Approaches for Structure Prediction - Structural Biology-2025 (France)
- Hybrid Approaches in Structure Prediction - Structural Biology 2025 (Germany)
- Membrane Proteins and Receptors - Structural Biology-2025 (France)
- Molecular Biology - Structural Biology 2025 (Germany)
- Molecular Biology Techniques - Structural Biology 2025 (Germany)
- Molecular Modelling and Dynamics - Structural Biology-2025 (France)
- Molecular Modelling and Dynamics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology 2025 (Germany)
- Proteomics and Genomics - Structural Biology-2025 (France)
- Sequencing Analysis - Structural Biology 2025 (Germany)
- Structural Bioinformatics - Structural Biology 2025 (Germany)
- Structural Bioinformatics and Computational Biology - Structural Biology-2025 (France)
- Structural Biology - Structural Biology 2025 (Germany)
- Structural Biology Databases - Structural Biology 2025 (Germany)
- Structural Biology in Cancer Research - Structural Biology-2025 (France)
- Structural Biology in Cancer Research - Structural Biology 2025 (Germany)
- Structural Enzymology - Structural Biology 2025 (Germany)
- Structural Virology - Structural Biology-2025 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2025 (France)
- Structure-Based Drug Discovery - Structural Biology-2025 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2025 (France)
- Structure-Function Relationships - Structural Biology-2025 (France)
- The Structural Basis of Disease - Structural Biology-2025 (France)